AMA recognizes the following companies as the key players who are driving Oral Osmotic Laxative market, some of them are Abbott Laboratories (United States), Bayer AG (Germany), Procter and Gamble Company (United States), GlaxoSmithKline Consumer Healthcare (United Kingdom), Purdue Pharma (United States), Sucampo Pharmaceuticals (United States), Salix Pharmaceuticals (United States), Pharmos Corporation (United States), Lexicon Pharmaceuticals (United States) and Tioga Pharmaceuticals Inc. (United States).

According to the report, some of the important driving forces behind the market growth are “Prevalence of Constipation Due to Rapid Changing Lifestyles ”. The primary concern of any business is the reduction of the overall operating cost. The increased need for operating efficiency and meeting regulatory demands at the same time have become major challenges for the original Players, additional restraints impacting market are “Skewed Player Distribution ” which is continuously seeking attention of Industry Experts and Decision makers.

The study was conducted using primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market study and vendor landscape in addition to a SWOT analysis of the key Players.

Available Customization: List of players that can be included in the study on immediate basis are Alimentary Health Limited (Ireland), Perrigo Company plc (Ireland), Sebela Pharmaceuticals Inc. (United States) and Boehringer Ingelheim Pharmaceuticals (Germany).